Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Biotech
Health
The Readout

Biopharma’s earningspalooza & parsing Trump’s big speech

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Jan. 23, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for January 23, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Stéphane Bancel, Bernie Sanders spar over what Moderna owes…
Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government
Cerebral and other telehealth startups face new legal and…
Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain
How Biogen got Aduhelm approved, Sanofi’s future in mRNA,…
How Biogen got Aduhelm approved, Sanofi’s future in mRNA, & Celgene’s endless saga

Recommended Stories